Bintrafusp alfa (M7824)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Bintrafusp alfa (M7824), covering 2022-03-22 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies [Phase 1]